Related Articles
Learn more about [why choose China for endoscopy](https://mymedvia.com/endoscopy-gastroscopy-in-china/why-choose-china-for-gastroscopy-colonoscopy-2026-complete-guide/) and [how to skip the long wait](https://mymedvia.com/endoscopy-gastroscopy-in-china/how-to-skip-the-long-wait-for-endoscopy-2026-complete-guide/).
Sarah, 58, from Vancouver, waited 11 months for her colonoscopy after a positive FIT test. By the time they found the tumor, it was Stage III. Her oncologist said something she’ll never forget: “If we’d caught this a year earlier, this would have been a very different conversation.”
Sarah’s story isn’t unusual. It’s a statistical inevitability in healthcare systems where endoscopy wait times stretch into months. And the data on what those delays cost — in progression, in survival rates, in treatment options — is harrowing.
What the Numbers Say About Delay
A landmark study published in Gastroenterology (January 2021) tracked over 200,000 U.S. Veterans who had an abnormal stool-based screening test (FIT or FOBT) and needed a follow-up colonoscopy. The findings were stark:
Colonoscopy delayed beyond 13 months → odds of colorectal cancer 1.3× higherColonoscopy delayed beyond 16 months → odds of advanced-stage cancer 1.7× higherColonoscopy delayed beyond 19 months → risk of colorectal cancer–related death 1.5× higher（Source: May FP, et al. “Time to Colonoscopy After Abnormal Fecal Blood Testing and Risk of Colorectal Cancer Incidence and Mortality.” Gastroenterology, 2021）
The research team concluded with a recommendation that colonoscopy should occur within one year of an abnormal stool test. The problem: in Canada, the median wait between a GP referral and receipt of treatment across all specialties was 28.6 weeks (over 7 months) in 2025, according to the Fraser Institute’s annual “Waiting Your Turn” report. For gastroenterology specifically, wait times for specialist consultation alone can stretch to 3–4 months in many provinces — and that’s before you even get scheduled for the scope.
In the UK, the NHS diagnostic waiting list has reached crisis levels: as of September 2025, 386,849 people had been waiting more than six weeks for a diagnostic test for cancer, heart problems, and other serious conditions. （Source: The Guardian, “NHS test delays putting hundreds of thousands at risk, say doctors,” November 2025）
The Math of Cancer Progression
Colorectal cancer doesn’t wait. It progresses. And the difference between catching it early versus late is measured in survival probabilities that shouldn’t be acceptable to anyone:
| Stage at Diagnosis | 5-Year Relative Survival |
|---|---|
| Localized (Stage I) | ~91% |
| Regional (Stage II–III) | ~73% |
| Distant (Stage IV) | ~15% |
（Source: American Cancer Society. “Colorectal Cancer Statistics, 2026.” CA: A Cancer Journal for Clinicians, 2026）
That’s not a small gap. That’s the difference between a 91% chance of being alive in five years and a 15% chance — driven largely by whether someone got a timely scope or spent months on a waitlist.
Early Gastric Cancer: The Same Pattern
The dynamics are even more dramatic for gastric (stomach) cancer, which accounts for a significant disease burden in both Western and Asian populations. Early gastric cancer treated with endoscopic or surgical resection carries a 5-year survival rate of 96–97%. But when diagnosed at an advanced stage, the five-year survival drops to below 20%. Yet approximately 60% of gastric cancer patients in many Western countries are diagnosed at a late stage, partly because diagnostic endoscopy — the gold standard for detection — is not always readily accessible.
（Source: JAMA Network, “Gastric Cancer: A Review,” 2024; ScienceDirect, “Gastric Cancer—Epidemiology, Modifiable and Non-modifiable Risk Factors,” 2024）
The Hidden Costs Beyond Survival
Survival rates are the headline metric, but delayed diagnosis extracts costs far beyond mortality:
More aggressive treatment: Late-stage CRC often requires extensive surgery + chemotherapy + radiation — versus a simple polypectomy during colonoscopy for early lesions.Higher financial burden: The cost of treating Stage IV colorectal cancer can be 3–5× the cost of treating Stage I disease, accounting for surgery, drug regimens, hospital stays, and supportive care.Lost quality of life: A patient who could have had one outpatient procedure instead faces months of treatment, recovery, and the psychological toll of advanced cancer.Lost productive years: CRC diagnosed at age 50 (localized) versus age 52 (metastatic) can mean the difference between full recovery and years stolen from work, family, and living.### The Pathologies That Worsen With Waiting
Beyond cancer, many non-malignant GI conditions deteriorate during prolonged waits:
Inflammatory Bowel Disease (Crohn’s, Ulcerative Colitis): Delayed diagnosis → irreversible bowel damage → strictures, fistulas, surgery that could have been avoided with earlier biologic therapy.Barrett’s Esophagus: The precursor to esophageal adenocarcinoma — surveillance endoscopy intervals matter. Missed scopes = missed dysplasia progression.H. pylori–related gastritis: A 10-minute gastroscopy can diagnose and guide eradication. Left untreated, H. pylori is a WHO Class I carcinogen for gastric cancer.### Why “Just Wait” Is No Longer Acceptable
The healthcare systems in Canada, the UK, and much of Europe were built on a promise of universal access. That promise is not being kept for diagnostic endoscopy. The data is unambiguous: waiting months for a scope is not a neutral act. It changes the biology of disease. It worsens outcomes.
The good news: you don’t have to wait. At myMedVia, we connect patients to JCI-accredited hospitals in China where colonoscopy and gastroscopy can be scheduled within days to 2 weeks — not months. The same gold-standard equipment (Olympus EVIS X1), the same safety protocols, the same quality — just without the queue.
What You Can Do Today
If you have symptoms (blood in stool, unexplained weight loss, persistent abdominal pain, change in bowel habits) — do not accept a multi-month wait.If you’ve had an abnormal FIT/FOBT result — the clock is ticking. Every month beyond 12 increases your risk.If you simply need screening and your system says “wait” — explore your options.The cost of waiting isn’t just measured in anxiety and frustration. It’s measured in cancer stage migration, in survival curves, in treatment intensity, and — in the worst cases — in lives lost that didn’t need to be.